Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410197 | SCV000485357 | likely pathogenic | Ataxia-telangiectasia syndrome | 2015-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000410197 | SCV003244611 | pathogenic | Ataxia-telangiectasia syndrome | 2022-07-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn1000Lysfs*10) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATM-related conditions. ClinVar contains an entry for this variant (Variation ID: 370122). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003470323 | SCV004210336 | likely pathogenic | Familial cancer of breast | 2023-05-30 | criteria provided, single submitter | clinical testing |